DNA methylation-driven EMT is a common mechanism of resistance to various therapeutic agents in cancer. [electronic resource]
Producer: 20210602Description: 27 p. digitalISSN:- 1868-7083
- Azacitidine -- therapeutic use
- Carcinoma, Hepatocellular -- drug therapy
- Cell Line, Tumor -- drug effects
- Circulating Tumor DNA -- genetics
- DNA Methylation -- genetics
- Drug Resistance, Neoplasm -- genetics
- Enzyme Inhibitors -- therapeutic use
- Epigenesis, Genetic
- Epithelial-Mesenchymal Transition -- genetics
- Gene Expression Regulation, Neoplastic -- genetics
- Humans
- Liver Neoplasms -- pathology
- MicroRNAs -- genetics
- Protein Kinase Inhibitors -- therapeutic use
- Sorafenib -- therapeutic use
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.